Pharmaceutical composition for treating rheumatism and rheumatoid arthritis

A rheumatoid, composition technology, applied in the direction of drug combinations, antipyretics, anti-inflammatory agents, etc., can solve the problems of teratogenicity, disability, and high misdiagnosis rate

Inactive Publication Date: 2012-03-28
张洪英
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Rheumatism is protracted, recurrent, and severely deformed and disabled, and often accompanied by serious complications, such as heart damage, pleura and lung damage, nervous system damage, kidney damage, etc., known as "undead cancer". Its stubborn and disabling nature causes great suffering to patients, and the misdiagnosis rate is extremely high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating rheumatism and rheumatoid arthritis
  • Pharmaceutical composition for treating rheumatism and rheumatoid arthritis
  • Pharmaceutical composition for treating rheumatism and rheumatoid arthritis

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0018] 1. Clinical observation

[0019] Plaster of the present invention (prepared according to the method of Example 1) treats 100 cases of rheumatic rheumatoid arthritis pain, including 50 cases of men and 50 cases of women.

[0020] Choose Luofushan rheumatoid plaster as a control group, produced by Guangdong Luofushan Chinese Medicine Co., Ltd., to treat 100 cases of rheumatoid arthritis, including 50 males and 50 females.

[0021] 2. Drug selection

[0022] Treatment group: plaster of the present invention (prepared according to the method of Example 1), 10g / paste, one plaster / 2 days.

[0023] Control group: Luofushan rheumatism plaster, produced by Guangdong Luofushan Chinese Medicine Co., Ltd., specification: 10g / patch, one patch / 2 days.

[0024] 3. Diagnostic criteria

[0025] ①Medical history: There is a history of invasion by wind-cold-damp evil.

[0026] ②Symptoms: Joint or muscle aches, numbness, pain, even severe pain, difficulty in moving, aggravated by cold....

experiment example 2

[0044] Experimental example two, typical case

[0045] Case 1: Liu, female, 59 years old. occupation, teacher. Symptoms: The knee joints of the patient's legs were painful and swollen for more than ten years, and it was inconvenient to walk. The condition was aggravated due to labor, and it was diagnosed as rheumatism. Treat a course of treatment (one course of treatment / 12 days) by pasting plaster of the present invention (prepared according to embodiment 1 method), joint swelling and pain obviously take a turn for the better, double knee joint function is obviously improved, continue pasting plaster of the present invention to treat three courses of treatment, after Inspections have basically returned to normal.

[0046] Case 2: Liang, male, 63 years old. Symptoms: I have been diagnosed with rheumatoid arthritis for more than ten years, and my ankle joints sometimes hurt, with slight swelling, and my activities are difficult. After three days of treatment by using the oi...

Embodiment 1

[0049] Embodiment 1 plaster

[0050]

[0051] The above-mentioned medicine is added into conventional auxiliary materials according to the conventional process to make a plaster, 10g / paste, one plaster / 2 days.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating rheumatism and rheumatoid arthritis, which consists of semiliquidambar cathayensis, geranium wilfordii, radix aconiti carmichaeli, berba aristolochiae mollissimae, schizophragma integrifolium, common threewingnut root, daemonorops draco, nux vomica, mistletoe, stropanthus divericatus, erycibe obtusifolia, akebiaquinata and mole cricket. The pharmaceutical composition can be made into clinically acceptable emplastrum, ointment, aerosol, liniment or tincture by adding conventional auxiliary materials according to a conventional process. The pharmaceutical composition has the efficacies of expelling wind and removing dampness, eliminating swelling and alleviating pain, promoting blood circulation and removing blood stasis, andwarming and activating meridian, and significant effect in the treatment of rheumatism and rheumatoid arthritis without toxic side effects.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating rheumatic rheumatoid arthritis. Background technique [0002] Rheumatism belongs to the category of arthralgia. "The so-called arthralgia is caused by the wind, cold and dampness at the time." There are many causes of the disease, but they are nothing more than external and internal causes. "Su Wen Bi Lun" pointed out brilliantly: "The three qi of wind, cold and damp are mixed together, and together they form numbness...". Modern medicine then thinks that the pathogenesis factor of rheumatism is except wind, cold, dampness, also includes infection, immunity, metabolism, endocrine, degeneration, heredity, tumor etc. Refers to the disease caused by the combination of wind and dampness. According to statistics, there are more than 200 million patients with rheumatism and rheumatoid arthritis in my country, accounting for 18% of the total pop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/889A61K36/896A61P19/02A61P29/00A61K35/64
Inventor 张洪英
Owner 张洪英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap